medical guideline

首页 肿瘤学指南 乳腺肿瘤 详情

Ribociclib with Fulvestrant for Treating Hormone Receptor-positive, HER2-negative Advanced Breast Cancer after Endocrine Therapy

原文:2021年 发布于 National Institute for Health and Care Excellence 浏览量:380 原文链接

作者: National Institute for Health and Care Excellence

归属分类: 所属人体系统: 生殖 | 分类: 乳腺肿瘤

关键词: Breast Cancer treatment hormone HER2 Ribociclib fulvestrant

指南简介